[ad_1]
Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing and a leader in clinical diagnostic testing, announced a share purchase agreement with Transgenic Inc. (2342: JP, Tokyo Stock Exchange) to acquire Genetic Lab Co. ,Ltd. (“G Lab”), a provider of diagnostics, biomarker development and drug discovery testing based on molecular biology. This acquisition will further strengthen Eurofins’ expansion in Asia and complement its global network of clinical diagnostic laboratories focused on professional and advanced genetic testing.
G Lab has more than 70 employees and generated more than 13 million euros in revenue in the fiscal year ending in March 2021. initial…
The full story on Benzinga.com
[ad_2]
Source link
